The 2024 Nobel Prize in Physiology or Medicine was awarded to researchers Victor Ambros of Chan Medical School at the University of Massachusetts and Gary Ruvkun of Harvard Medical School. Their pioneering research on microRNA, a fundamental component in cellular development and regulation, has earned them this prestigious recognition.
The announcement made by the Nobel Assembly at Karolinska Institutet highlighted the importance of their work, which uses the tiny nematode Caenorhabditis elegans to uncover fundamental gene regulatory mechanisms that affect all multicellular organisms, including humans.
Both Ambros and Ruvkun expressed surprise and gratitude upon receiving the news, underlining the unique prestige of the Nobel Prize among the various awards obtained throughout their careers. Their discovery opened new avenues in understanding how organisms develop and the genetic dysfunctions that can lead to disease, setting a new standard in the field of genetic research.
